Literature DB >> 17107531

Familial cerebral cavernous haemangioma diagnosed in an infant with a rapidly growing cerebral lesion.

B H K Ng1, E Mulyadi, J K Pereira, S Ghedia, J Pinner, D Mowat, M Vonau.   

Abstract

Cavernous haemangiomas of the central nervous system are vascular malformations best imaged by MRI. They may present at any age, but to our knowledge only 39 cases in the first year of life have previously been reported. A familial form has been described and some of the underlying genetic mutations have recently been discovered. We present the clinical features and serial MRI findings of an 8-week-old boy who presented with subacute intracranial haemorrhage followed by rapid growth of a surgically proven cavernous haemangioma, mimicking a tumour. He also developed new lesions. A strong family history of neurological disease was elucidated. A familial form of cavernous haemangioma was confirmed by identification of a KRIT 1 gene mutation and cavernous haemangiomas in the patient and other family members. We stress the importance of considering cavernous haemangiomas in the context of intracerebral haemorrhage and in the differential diagnosis of rapidly growing lesions in this age group. The family history is also important in screening for familial disease.

Entities:  

Mesh:

Year:  2006        PMID: 17107531     DOI: 10.1111/j.1440-1673.2006.01638.x

Source DB:  PubMed          Journal:  Australas Radiol        ISSN: 0004-8461


  7 in total

1.  Stabilization of VEGFR2 signaling by cerebral cavernous malformation 3 is critical for vascular development.

Authors:  Yun He; Haifeng Zhang; Luyang Yu; Murat Gunel; Titus J Boggon; Hong Chen; Wang Min
Journal:  Sci Signal       Date:  2010-04-06       Impact factor: 8.192

2.  Cutaneous venous malformations related to KRIT1 mutation: case report and literature review.

Authors:  Francesca Romana Grippaudo; Maria Piane; Matteo Amoroso; Benedetto Longo; Silvana Penco; Luciana Chessa; Maria Giubettini; Fabio Santanelli
Journal:  J Mol Neurosci       Date:  2013-07-05       Impact factor: 3.444

Review 3.  Spontaneous bleeding into a suprasellar cavernous angioma of a neonate: case report and literature review.

Authors:  Suhas Udayakumaran; Dimitrios Paraskevopoulos; Emanuela Cagnano; Jonathan Roth; Shlomi Constantini
Journal:  Childs Nerv Syst       Date:  2010-04-24       Impact factor: 1.475

4.  Unilateral facial palsy in an infant: an unusual presentation of familial multiple cerebral cavernous malformation.

Authors:  Zaitun Zakaria; Chandrasekaran Kaliaperumal; John Caird; Mohammad Sattar
Journal:  BMJ Case Rep       Date:  2012-11-30

5.  CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations.

Authors:  Katrin Voss; Sonja Stahl; Elisa Schleider; Sybille Ullrich; Joachim Nickel; Thomas D Mueller; Ute Felbor
Journal:  Neurogenetics       Date:  2007-07-27       Impact factor: 2.660

6.  Predictive genetic testing of at-risk relatives requires analysis of all CCM genes after identification of an unclassified CCM1 variant in an individual affected with cerebral cavernous malformations.

Authors:  Winnie Schröder; Juliane Najm; Stefanie Spiegler; Martina Mair; Julio Viera; Wolfram Henn; Ute Felbor
Journal:  Neurosurg Rev       Date:  2013-05-31       Impact factor: 3.042

7.  High mutation detection rates in cerebral cavernous malformation upon stringent inclusion criteria: one-third of probands are minors.

Authors:  Stefanie Spiegler; Juliane Najm; Jian Liu; Stephanie Gkalympoudis; Winnie Schröder; Guntram Borck; Knut Brockmann; Miriam Elbracht; Christine Fauth; Andreas Ferbert; Leonie Freudenberg; Ute Grasshoff; Yorck Hellenbroich; Wolfram Henn; Sabine Hoffjan; Irina Hüning; G Christoph Korenke; Peter M Kroisel; Erdmute Kunstmann; Martina Mair; Susanne Munk-Schulenburg; Omid Nikoubashman; Silke Pauli; Sabine Rudnik-Schöneborn; Irene Sudholt; Ulrich Sure; Sigrid Tinschert; Michaela Wiednig; Barbara Zoll; Mark H Ginsberg; Ute Felbor
Journal:  Mol Genet Genomic Med       Date:  2014-01-14       Impact factor: 2.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.